Cite
MLA Citation
Paul G Richardson et al.. “Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.” Lancet oncology, vol. 20, no. 6, 2019, pp. 781–794. http://access.bl.uk/ark:/81055/vdc_100084768814.0x000013